Rtx A/s · OMXCOP:RTX

Rtx A/s — Q2/H1 2024/25 Earnings Presentation

26 slides from Rtx A/s's earnings presentation, May 2025

  1. Slide 1: Investor Presentation Q2/H1 2024/25

    Click here to view the live event of the presentation Investor Presentation Q2/H1 - 2024/25 This presentation contains statements regarding expectations for the future development of RTX A/S, including future revenue and operating profit (EBITDA), reflect Management’s current outlook and carry some

  2. Slide 2: A significant improvement in the global technology company RTX

    A significant improvement in the global technology company RTX › Growth in Enterprise › Growing Healthcare revenue › Tariff creates uncertainty 2024/25 Q2/H1 - RTX - Investor Presentation 2

  3. Slide 3: Agenda

    Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 3

  4. Slide 4: Helping people perform at their best

    Helping people perform at their best Utilizing wireless expertise, we provide secure and reliable communication products and solutions, fit for challenging environments 2024/25 Q2/H1 - RTX - Investor Presentation 4

  5. Slide 5: Creating value through trusted partnerships

    Creating value through trusted partnerships Enabling global leaders to focus on brand and market development by designing and producing high-quality communication products and solutions 2024/25 Q2/H1 - RTX - Investor Presentation 5

  6. Slide 6: Trusted partnerships throughout the product lifecycle

    Trusted partnerships throughout the product lifecycle Branding and Sales Distribution Support Customers Market Requirements marketing analysis and design Support and Market Collaborative product development Go-to-market Sales, production, and distribution lifecycle research management Onboarding Pro

  7. Slide 7: Agenda

    Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 7

  8. Slide 8: Enterprise products and customers

    Enterprise products and customers 2024/25 Q2/H1 - RTX - Investor Presentation 8

  9. Slide 9: Enterprise update

    Enterprise update Infrastructure, Handset, and Headset Highlights › Growth driven primarily by retail and normalization in key customer demand patterns › Continuously strong orderbook from several long-term customers › Order horizon remains short at three to six months Revenue Q2: 114 DKKm H1: 193 D

  10. Slide 10: Enterprise – Retail insights

    Enterprise – Retail insights Value creation › Labour efficiency › Customer experience › Operational excellence 2024/25 Q2/H1 - RTX - Investor Presentation 10

  11. Slide 11: Healthcare products, customers and potential partners

    Healthcare products, customers and potential partners Customers Devices and monitoring Hospital IT infrastructure 2024/25 Q2/H1 - RTX - Investor Presentation 11

  12. Slide 12: Healthcare update

    Healthcare update Infrastructure for patient monitoring solutions Highlights › Revenue for the quarter on key infrastructure products and modules for patient monitoring devices › Building up orderbook on key products › Transition to full product ownership and seamless integration in progress with pa

  13. Slide 13: ProAudio – Secure and reliable sound

    ProAudio – Secure and reliable sound Standard RTX modules Software solutions › TeamEngage® › Sheerlink® › Sheersound® 2024/25 Q2/H1 - RTX - Investor Presentation 13

  14. Slide 14: ProAudio update

    ProAudio update Connectivity modules for professional audio solutions Highlights › Revenue is below expectations, reflecting a lower volume from key customers and a longer development time for new customers › Strategic focus on module business, reduction in product business where we experience lower

  15. Slide 15: Agenda

    Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 15

  16. Slide 16: Selected insights – US tariffs impact on RTX

    Selected insights – US tariffs impact on RTX Current Tariffs RTX Production footprint & Operating Model At key production sites* › Customers are the importers of goods 10% 30% 10% Philippines China Denmark › RTX has an asset-light setup and production partner with global footprint › Optimization of

  17. Slide 17: Agenda

    Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 17

  18. Slide 18: Interim Report H1 2024/25

    Interim Report H1 2024/25 2024/25 Q2/H1 - RTX - Investor Presentation 18

  19. Slide 19: Revenue

    Revenue Revenue Revenue DKK million Q2: 160 DKKm 300 500 Revenue Q2 2023/24: 125 DKKm 498 400 250 H1: 260 DKKm 200 260 349 300 Revenue H1 2023/24: 207 DKKm 200 101 207 150 100 Strong performance in Enterprise from key 82 0 customers. Revenue as expected for H1 for 100 Healthcare. ProAudio below expe

  20. Slide 20: Gross Margin

    Gross Margin Gross Margin Gross Margin % Q2: 49.7 % 150 60 Gross margin Q2 2023/24: 45.6% 50,8% 50,1% 50 H1: 50.1 % 100 46,7% Gross margin H1 2023/24: 42.9% 44,9% 40 42,9% 38,9% As anticipated, we see a robust gross margin 30 in H1. This is a result of both product mix, 50 healthcare revenue and cos

  21. Slide 21: EBITDA

    EBITDA EBITDA EBITDA DKK million Q2: 16.6 DKKm 100 50 EBITDA Q2 2023/24: 0.9 DKKm 7 80 -9 0 H1: 7.2 DKKm 60 3 EBITDA H1 2023/24: -29.5 DKKm -20 40 -31 -30 -50 20 17 The development in EBITDA for the period is -100 23 impacted mainly by the revenue level and 1 9 0 improved gross margin compared to sa

  22. Slide 22: Other key financial highlight

    Other key financial highlight Inventory Free Cash Flow Net liquidity position H1: 74 DKKm H1: 7 DKKm H1: 108 DKKm LY: 100 DKKm LY: -35 DKKm LY: 87 DKKm Inventory end of H1 reached Free Cash flow for the quarter Net liquidity position end of 74 DKKm, down from 82 was positive by 21 DKKm, H1 reached 1

  23. Slide 23: Agenda

    Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 23

  24. Slide 24: Outlook FY - 2024/25

    Outlook FY - 2024/25 2024/25 Financial Outlook 2024/25 Outlook is maintained As communicated in annual report November 2024 Revenue: Revenue: 490 to 520 DKKm › Growth in Enterprise and Healthcare › Short visibility gives insight on 3-6 months forecast › Orderbook is building up EBITDA / EBIT: EBITDA

  25. Slide 25: Agenda

    Agenda 1. About RTX 2. Key Highlights and Business Update 3. Selected insights – US Tariffs and RTX 4. Financial Highlights for Q2/H1 2024/25 5. Outlook 6. Q&A 2024/25 Q2/H1 - RTX - Investor Presentation 25

  26. Slide 26: Questions?

    Questions? 2024/25 Q2/H1 - RTX - Investor Presentation 26

RTX — Q2/H1 2024/25 Earnings Presentation on 6ix